Know Cancer

or
forgot password

    • cancer clinical trials in columbia, MD

    • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Central Maryland Oncology Center
    Columbia, Maryland 21044
    Prostate Cancer
    PhII ICb With/Without Erbitux in MBC Pts
    Maryland Oncology Hematology, P.A.
    Columbia, Maryland 21044
    Metastatic Breast Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Central Maryland Oncology Center
    Columbia, Maryland 21044
    Prostate Cancer
    Predicting Risk of Cancer in Barrett's Esophagus
    Johns Hopkins at Howard County General Hospital
    Columbia, Maryland 21044
    Barrett Esophagus, Esophageal Neoplasm, Gastroesophageal Reflux
    Adj TC + Herceptin Early Stage Breast Cancer
    Maryland Oncology Hematology, P.A.
    Columbia, Maryland 21044
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Maryland Oncology Hematology, P.A.
    Columbia, Maryland 21044
    Breast Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Central Maryland Oncology Center
    Columbia, Maryland 21044
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Phase II Sunitinib Prog Met AIPC
    Maryland Oncology Hematology, P.A.
    Columbia, Maryland 21044
    Metastatic Prostate Cancer
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Central Maryland Oncology Center
    Columbia, Maryland 21044
    Prostate Cancer, Sexual Dysfunction
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Central Maryland Oncology Center
    Columbia, Maryland 21044
    Prostate Cancer
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Maryland Oncology Hematology, P.A.
    Columbia, Maryland 21044
    Adenocarcinoma of the Lung
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Maryland Oncology Hematology PA
    Columbia, Maryland 21044
    Chronic Myeloid Leukemia
    Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Central Maryland Oncology Center
    Columbia, Maryland 21044
    Prostate Cancer
    Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
    Howard County GIDC
    Columbia, Maryland 21044
    Ulcerative Colitis
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Maryland Oncology Hematology, P.A.
    Columbia, Maryland 21044
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Afatinib Expanded Access Program
    1200.45.019 Boehringer Ingelheim Investigational Site
    Columbia, Maryland
    Carcinoma, Non-Small-Cell Lung
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Central Maryland Oncology Center
    Columbia, Maryland 21044
    Non-Small Cell Lung Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Maryland Oncology Hematology, P.A.
    Columbia, Maryland 21044
    Carcinoma, Non-Small-Cell Lung
    Non-small Cell Lung Cancer Registry
    Maryland Oncology
    Columbia, Maryland 21044
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Maryland Oncology-Hematology PA
    Columbia, Maryland 21044
    Multiple Myeloma
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Maryland Oncology Hematology, P.A.
    Columbia, Maryland 21044
    Colorectal Cancer Metastatic
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Maryland Oncology Hematology, PA
    Columbia, Maryland 21044
    Metastatic Breast Cancer
    Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
    Maryland Oncology Hematology, PA
    Columbia, Maryland 21044
    Small Cell Lung Cancer
    Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
    Maryland Oncology Hematology, PA
    Columbia, Maryland 21044
    Small Cell Lung Cancer
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Cardiovascular Specialists Of Central Maryland, P.A.
    Columbia, Maryland 21044
    Atrial Fibrillation, Atrial Flutter
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Maryland Oncology Hematology, P.A.
    Columbia, Maryland 21044
    Metastatic Breast Cancer
    Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer
    Central Maryland Radiation Oncology in Howard County
    Columbia, Maryland 21044
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
    Columbia Medical Practice

    Trial Locations
    Columbia Medical Practice
    Howard County GIDC
    Russell Schub
    Gasro Center of Maryland
    Gastro Center of Maryland
    Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer